{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Garg S"],"funding":["NCATS NIH HHS"],"pagination":["1034-1041"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC4575632"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["8(9)"],"pubmed_abstract":["<h4>Objectives</h4>This study was performed to determine whether a 4-tiered classification of left ventricular hypertrophy (LVH) defines subgroups in the general population that are at variable risks of adverse cardiovascular (CV) outcomes.<h4>Background</h4>We recently proposed a 4-tiered classification of LVH where eccentric LVH is subdivided into \"indeterminate hypertrophy\" and \"dilated hypertrophy\" and concentric LVH into \"thick hypertrophy\" and \"both thick and dilated hypertrophy,\" based on the presence of increased left ventricular (LV) end-diastolic volume.<h4>Methods</h4>Participants from the Dallas Heart study who underwent cardiac magnetic resonance and did not have LV dysfunction or a history of heart failure (HF) (n = 2,458) were followed for a median of 9 years for the primary"],"journal":["JACC. Cardiovascular imaging"],"pubmed_title":["Association of a 4-Tiered Classification of LV Hypertrophy With Adverse CV Outcomes in the General Population."],"pmcid":["PMC4575632"],"funding_grant_id":["UL1TR001105","UL1 TR001105"],"pubmed_authors":["de Lemos JA","Ayers C","Garg S","Khouri MG","Drazner MH","Pandey A","Berry JD","Peshock RM"],"additional_accession":[]},"is_claimable":false,"name":"Association of a 4-Tiered Classification of LV Hypertrophy With Adverse CV Outcomes in the General Population.","description":"<h4>Objectives</h4>This study was performed to determine whether a 4-tiered classification of left ventricular hypertrophy (LVH) defines subgroups in the general population that are at variable risks of adverse cardiovascular (CV) outcomes.<h4>Background</h4>We recently proposed a 4-tiered classification of LVH where eccentric LVH is subdivided into \"indeterminate hypertrophy\" and \"dilated hypertrophy\" and concentric LVH into \"thick hypertrophy\" and \"both thick and dilated hypertrophy,\" based on the presence of increased left ventricular (LV) end-diastolic volume.<h4>Methods</h4>Participants from the Dallas Heart study who underwent cardiac magnetic resonance and did not have LV dysfunction or a history of heart failure (HF) (n = 2,458) were followed for a median of 9 years for the primary","dates":{"release":"2015-01-01T00:00:00Z","publication":"2015 Sep","modification":"2025-04-22T20:44:42.448Z","creation":"2019-03-27T01:58:39Z"},"accession":"S-EPMC4575632","cross_references":{"pubmed":["26298074"],"doi":["10.1016/j.jcmg.2015.06.007"]}}